新型查尔酮衍生物的合成及抗肿瘤活性评价（英文）

Synthesis and Evaluation of Chalcone Derivatives as Novel Anticancer Agents

主要通过 Claisen-Schmidt 缩合反应设计合成了一系列含有哌啶、吗啡啉、N-甲基哌嗪取代的查尔酮衍生物,并通过噻唑蓝(MTT)法对 MCF-7(人乳腺癌细胞系)、A549(人肺癌细胞系)、HL-60(人白血病细胞系)、Hela(人宫颈癌细胞系)和 Bewo(人绒毛肿瘤细胞系)等五种癌细胞系进行了体外抗癌活性研究.研究表明,化合物 4a, 4e, 4f, 4j, 4m, 4o 对MCF-7, A549, HL-60 三种癌细胞系抗癌活性最佳, IC50 值均在 10 μmol/L 以下.

Three series of chalcones bearing a piperidino, morpholino, and 1-methylpiperazino moiety were synthesized in two steps with the key step being Claisen-Schmidt condensation and tested for the activity against five cell lines, MCF-7 (human breast adenocarcinoma cell line), A549 (human lung adenocarcinoma epithelial cell line), HL-60 (human leukemia cell line), Hela (human cervical cancer cell line), and Bewo (human chorionic tumor cell line) by thiazolyl blue tetrazolium bromide (MTT) assay. Some chalcones exhibited good anticancer activity, and among them 4a, 4e, 4f, 4j, 4m, and 4o displayed the best anticancer activity for MCF-7 breast cancer cells, A549 lung cancer cells, and HL-60 leukemia cancer cells with IC50 values below 10 μmol/L, respectively.